20th Feb 2025 07:00
BIOPHARMA CREDIT PLC
(the "Company")
NOTICE OF FULL YEAR RESULTS
BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt investor, will announce its Full Year Results for the period ending 31 December 2024 on Tuesday, 25 March 2025.
A sell side presentation will be delivered at 15.00 GMT through a webcast facility. To register to attend or request details, RSVP to [email protected].
-Ends-
Enquiries
Burson Buchanan
Mark Court / Jamie Hooper / Henry Wilson / Samuel Adams
+44 (0) 20 7466 5000
Notes to Editors
BioPharma Credit PLC is London's only specialist debt investor to the life sciences industry and joined the LSE in March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.